{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:40:20Z","timestamp":1789620020898,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Foundation for Medical Research","doi-asserted-by":"publisher","award":["FRM DEQ20150331689"],"award-info":[{"award-number":["FRM DEQ20150331689"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofhospitalinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jhin.2024.12.013","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T11:12:11Z","timestamp":1739358731000},"page":"109-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Optimization and evaluation of new decontamination procedures inactivating human prions"],"prefix":"10.1016","volume":"160","author":[{"given":"L.","family":"Herzog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Reine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Castille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Passet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Moudjou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-L.","family":"Vilotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"B\u00e9ringue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Igel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2024.12.013_bib1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","article-title":"Prion diseases of humans and animals: their causes and molecular basis","volume":"24","author":"Collinge","year":"2001","journal-title":"Annu Rev Neurosci"},{"issue":"5090","key":"10.1016\/j.jhin.2024.12.013_bib2","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/214764a0","article-title":"Does the agent of scrapie replicate without nucleic acid?","volume":"214","author":"Alper","year":"1967","journal-title":"Nature"},{"issue":"8009","key":"10.1016\/j.jhin.2024.12.013_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0140-6736(77)91958-4","article-title":"Danger of accidental person-to-person transmission of Creutzfeldt\u2013Jakob disease by surgery","volume":"1","author":"Bernoulli","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.jhin.2024.12.013_bib4","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJM198205273062107","article-title":"Chemical disinfection of Creutzfeldt\u2013Jakob disease virus","volume":"306","author":"Brown","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhin.2024.12.013_bib5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/infdis\/145.2.683","article-title":"Effect of chemicals, heat, and histopathologic processing on high-infectivity hamster-adapted scrapie virus","volume":"145","author":"Brown","year":"1982","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhin.2024.12.013_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00401-017-1791-x","article-title":"Neuropathology of iatrogenic Creutzfeldt\u2013Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology","volume":"135","author":"Duyckaerts","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jhin.2024.12.013_bib7","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jhin.2007.08.020","article-title":"Prion inactivation using a new gaseous hydrogen peroxide sterilisation process","volume":"67","author":"Fichet","year":"2007","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jhin.2024.12.013_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1099\/00221287-37-2-251","article-title":"Studies on the heat stability and chromatographic behaviour of the scrapie agent","volume":"37","author":"Hunter","year":"1964","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.jhin.2024.12.013_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0021-9975(65)90006-X","article-title":"Resistance of the scrapie agent to formalin","volume":"75","author":"Pattison","year":"1965","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.jhin.2024.12.013_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0378-1135(87)90084-8","article-title":"Ionising radiation has no influence on scrapie incubation period in mice","volume":"13","author":"Fraser","year":"1987","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.jhin.2024.12.013_bib11","first-page":"653","article-title":"The scrapie disease process is unaffected by ionising radiation","volume":"317","author":"Fraser","year":"1989","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.jhin.2024.12.013_bib12","doi-asserted-by":"crossref","DOI":"10.1515\/tnsci-2022-0315","article-title":"Human prion diseases and the prion protein \u2013 what is the current state of knowledge?","volume":"14","author":"Nafe","year":"2023","journal-title":"Transl Neurosci"},{"key":"10.1016\/j.jhin.2024.12.013_bib13","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1212\/WNL.55.8.1075","article-title":"Iatrogenic Creutzfeldt\u2013Jakob disease at the millennium","volume":"55","author":"Brown","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jhin.2024.12.013_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.44.1.179","article-title":"Creutzfeldt\u2013Jakob disease after pituitary-derived human growth hormone therapy: two cases with valine 129 homozygous genotype","volume":"44","author":"Masson","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jhin.2024.12.013_bib15","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1212\/WNL.56.8.1080","article-title":"Creutzfeldt\u2013Jakob disease after receipt of a previously unimplicated brand of dura mater graft","volume":"56","author":"Hannah","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jhin.2024.12.013_bib16","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM197403212901220","article-title":"Letter: Possible person-to-person transmission of Creutzfeldt\u2013Jakob disease","volume":"290","author":"Duffy","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhin.2024.12.013_bib17","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1086\/673986","article-title":"Management of neurosurgical instruments and patients exposed to Creutzfeldt\u2013Jakob disease","volume":"34","author":"Belay","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9192","key":"10.1016\/j.jhin.2024.12.013_bib18","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0140-6736(05)70594-8","article-title":"Contaminated surgical instruments and variant Creutzfeldt\u2013Jakob disease","volume":"354","author":"Laurenson","year":"1999","journal-title":"Lancet"},{"issue":"9154","key":"10.1016\/j.jhin.2024.12.013_bib19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0140-6736(98)08138-0","article-title":"Surgical treatment and risk of sporadic Creutzfeldt\u2013Jakob disease: a case\u2013control study","volume":"353","author":"Collins","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jhin.2024.12.013_bib20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp.2009.188425","article-title":"Nosocomial transmission of sporadic Creutzfeldt\u2013Jakob disease: results from a risk-based assessment of surgical interventions","volume":"82","author":"de Pedro-Cuesta","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jhin.2024.12.013_bib21","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00401-020-02153-7","article-title":"Prevalence in Britain of abnormal prion protein in human appendices before and after exposure to the cattle BSE epizootic","volume":"139","author":"Gill","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jhin.2024.12.013_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00401-021-02270-x","article-title":"Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients","volume":"141","author":"Douet","year":"2021","journal-title":"Acta Neuropathol"},{"issue":"417","key":"10.1016\/j.jhin.2024.12.013_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7785","article-title":"Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt\u2013Jakob disease","volume":"9","author":"Orr\u00fa","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhin.2024.12.013_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJMc2000687","article-title":"Variant Creutzfeldt\u2013Jakob disease diagnosed 7.5 years after occupational exposure","volume":"383","author":"Brandel","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhin.2024.12.013_bib25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/vr.142.18.474","article-title":"Studies on the efficacy of hyperbaric rendering procedures in inactivating bovine spongiform encephalopathy (BSE) and scrapie agents","volume":"142","author":"Schreuder","year":"1998","journal-title":"Vet Rec"},{"key":"10.1016\/j.jhin.2024.12.013_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01310794","article-title":"Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie","volume":"139","author":"Taylor","year":"1994","journal-title":"Arch Virol"},{"issue":"Pt 12","key":"10.1016\/j.jhin.2024.12.013_bib27","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1099\/0022-1317-83-12-3199","article-title":"Thermostability of mouse-passaged BSE and scrapie is independent of host PrP genotype: implications for the nature of the causal agents","volume":"83","author":"Taylor","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhin.2024.12.013_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0166-0934(93)90126-C","article-title":"Comparative analysis of scrapie agent inactivation methods","volume":"41","author":"Ernst","year":"1993","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jhin.2024.12.013_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/tvjl.1999.0406","article-title":"Inactivation of transmissible degenerative encephalopathy agents: a review","volume":"159","author":"Taylor","year":"2000","journal-title":"Vet J"},{"key":"10.1016\/j.jhin.2024.12.013_bib30","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1128\/JVI.78.4.2164-2165.2004","article-title":"Inactivation of transmissible spongiform encephalopathy (prion) agents by environ LpH","volume":"78","author":"Race","year":"2004","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.jhin.2024.12.013_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290325","article-title":"Efficacy of Wex-cide 128 disinfectant against multiple prion strains","volume":"18","author":"Baune","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jhin.2024.12.013_bib32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1128\/JVI.80.1.322-331.2006","article-title":"Inactivation of prions by acidic sodium dodecyl sulfate","volume":"80","author":"Peretz","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.jhin.2024.12.013_bib33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0022-510X(83)90021-7","article-title":"Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt\u2013Jakob and related agents","volume":"59","author":"Kimberlin","year":"1983","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jhin.2024.12.013_bib34","series-title":"WHO infection control guidelines for transmissible spongiform encephalopathies: report of a WHO consultation, Geneva, Switzerland, 23\u201326 March 1999","year":"2000"},{"key":"10.1016\/j.jhin.2024.12.013_bib35","unstructured":"ANSM. Liste des produits inactivants et format de dossier pour la rev. Available at: https:\/\/ansm.sante.fr\/vos-demarches\/industriel\/liste-des-produits-inactivants-et-format-de-dossier-pour-la-revendication-de-performances-dinactivation [last accessed March 20025]."},{"key":"10.1016\/j.jhin.2024.12.013_bib36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1099\/0022-1317-34-2-295","article-title":"Characteristics of a short incubation model of scrapie in the golden hamster","volume":"34","author":"Kimberlin","year":"1977","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhin.2024.12.013_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00649-19","article-title":"Correlation between bioassay and protein misfolding cyclic amplification for variant Creutzfeldt\u2013Jakob disease decontamination studies","volume":"5","author":"B\u00e9londrade","year":"2020","journal-title":"mSphere"},{"key":"10.1016\/j.jhin.2024.12.013_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146833","article-title":"Rapid and highly sensitive detection of variant Creutzfeldt\u2013Jakob disease abnormal prion protein on steel surfaces by protein misfolding cyclic amplification: application to prion decontamination studies","volume":"11","author":"Belondrade","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jhin.2024.12.013_bib39","unstructured":"ANSM. Protocole Standard Prion v2018. Available at: https:\/\/ansm.sante.fr\/vos-demarches\/industriel\/protocole-standard-prion-v2018 [last accessed March 20025]."},{"key":"10.1016\/j.jhin.2024.12.013_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.591024","article-title":"Improving the predictive value of prion inactivation validation methods to minimize the risks of iatrogenic transmission with medical instruments","volume":"8","author":"Moudjou","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jhin.2024.12.013_bib41","doi-asserted-by":"crossref","first-page":"10867","DOI":"10.1128\/JVI.01383-16","article-title":"Absence of evidence for a causal link between bovine spongiform encephalopathy strain variant L-BSE and known forms of sporadic Creutzfeldt\u2013Jakob disease in human PrP transgenic mice","volume":"90","author":"Jaumain","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.jhin.2024.12.013_bib42","doi-asserted-by":"crossref","first-page":"8678","DOI":"10.1128\/JVI.01118-14","article-title":"Accelerated, spleen-based titration of variant Creutzfeldt\u2013Jakob disease infectivity in transgenic mice expressing human prion protein with sensitivity comparable to that of survival time bioassay","volume":"88","author":"Halliez","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.jhin.2024.12.013_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001419","article-title":"Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD","volume":"3","author":"B\u00e9ringue","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jhin.2024.12.013_bib44","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3201\/eid1412.080941","article-title":"Transmission of atypical bovine prions to mice transgenic for human prion protein","volume":"14","author":"B\u00e9ringue","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jhin.2024.12.013_bib45","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/JVI.01356-06","article-title":"Sheep-passaged bovine spongiform encephalopathy agent exhibits altered pathobiological properties in bovine-PrP transgenic mice","volume":"81","author":"Espinosa","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhin.2024.12.013_bib46","article-title":"Highly infectious prions generated by a single round of microplate-based protein misfolding cyclic amplification","volume":"5","author":"Moudjou","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.jhin.2024.12.013_bib47","series-title":"Biosafety in microbiological and biomedical laboratories","year":"2024"},{"key":"10.1016\/j.jhin.2024.12.013_bib48","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2345\/0899-8205-54.5.332","article-title":"Review: Trends in processing prion-contaminated surgical instruments","volume":"54","author":"Bruna","year":"2020","journal-title":"Biomed Instrum Technol"},{"key":"10.1016\/j.jhin.2024.12.013_bib49","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3201\/eid2306.161734","article-title":"Distribution and quantitative estimates of variant Creutzfeldt\u2013Jakob disease prions in tissues of clinical and asymptomatic patients","volume":"23","author":"Douet","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"9433","key":"10.1016\/j.jhin.2024.12.013_bib50","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(04)16811-6","article-title":"Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient","volume":"364","author":"Peden","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jhin.2024.12.013_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000029","article-title":"Beyond PrP9res) type 1\/type 2 dichotomy in Creutzfeldt\u2013Jakob disease","volume":"4","author":"Uro-Coste","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhin.2024.12.013_bib52","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(05)70225-8","article-title":"Coexistence of multiple PrPSc types in individuals with Creutzfeldt\u2013Jakob disease","volume":"4","author":"Polymenidou","year":"2005","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.jhin.2024.12.013_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00393-20","article-title":"Prions from sporadic Creutzfeldt\u2013Jakob disease patients propagate as strain mixtures","volume":"11","author":"Cassard","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.jhin.2024.12.013_bib54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40478-021-01247-x","article-title":"Prion strains associated with iatrogenic CJD in French and UK human growth hormone recipients","volume":"9","author":"Douet","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.jhin.2024.12.013_bib55","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jhin.2011.09.004","article-title":"Limited efficacy of steam sterilization to inactivate vCJD infectivity","volume":"80","author":"Fernie","year":"2012","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jhin.2024.12.013_bib56","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhin.2022.08.014","article-title":"Kinetics of the reduction of Creutzfeldt\u2013Jakob disease prion seeding activity by steam sterilization support the use of validated 134\u00b0C programmes","volume":"132","author":"Schwenke","year":"2023","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jhin.2024.12.013_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47781-6","article-title":"Thermostability as a highly dependent prion strain feature","volume":"9","author":"Mar\u00edn-Moreno","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhin.2024.12.013_bib58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jhin.2006.09.025","article-title":"Effect of drying time, ambient temperature and pre-soaks on prion-infected tissue contamination levels on surgical stainless steel: concerns over prolonged transportation of instruments from theatre to central sterile service departments","volume":"65","author":"Lipscomb","year":"2007","journal-title":"J Hosp Infect"},{"issue":"Pt 4","key":"10.1016\/j.jhin.2024.12.013_bib59","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1042\/BA20060249","article-title":"Comparative studies on the thermostability of five strains of transmissible-spongiform-encephalopathy agent","volume":"47","author":"Fernie","year":"2007","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.jhin.2024.12.013_bib60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40478-017-0503-z","article-title":"Iatrogenic Creutzfeldt\u2013Jakob disease with amyloid-\u03b2 pathology: an international study","volume":"6","author":"Cali","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.jhin.2024.12.013_bib61","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/17474930231203133","article-title":"Iatrogenic cerebral amyloid angiopathy: a multinational case series and individual patient data analysis of the literature","volume":"19","author":"Pikija","year":"2024","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jhin.2024.12.013_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28856-2","article-title":"Assessment of the efficacy of different procedures that remove and disassemble alpha-synuclein, tau and A-beta fibrils from laboratory material and surfaces","volume":"8","author":"Fenyi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhin.2024.12.013_bib63","doi-asserted-by":"crossref","first-page":"12926","DOI":"10.1073\/pnas.0903200106","article-title":"Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation","volume":"106","author":"Eisele","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhin.2024.12.013_bib64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhin.2020.10.018","article-title":"Alpha-synuclein seeds of Parkinson\u2019s disease show high prion-exceeding resistance to steam sterilization","volume":"108","author":"Pinder","year":"2021","journal-title":"J Hosp Infect"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670125000301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670125000301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:27:45Z","timestamp":1762262865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670125000301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":64,"alternative-id":["S0195670125000301"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2024.12.013","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization and evaluation of new decontamination procedures inactivating human prions","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2024.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of The Healthcare Infection Society.","name":"copyright","label":"Copyright"}]}}